QSAR studies on imidazoles and sulfonamides as antidiabetic agents

[1]. J.L. Wolff, B. Starfield, G.F. Anderson, Prevalence, expenditures, and complications of multiple chronic conditions in the elderly, Arch Internal Medicine 162 (2002) 2269-2276.10.1001/archinte.162.20.2269Search in Google Scholar

[2]. K.M. Narayan, J.P. Boyle, L.S. Geiss, Impact of recent increase in incidence on future diabetes burden U.S., 2005-2050, Diabetes Care 29 (2006) 2114-2116.10.2337/dc06-1136Search in Google Scholar

[3]. R.A. Anderson, Chromium in the prevention of diabetes, Diabetes Metabolism 26 (2000) 22-27.Search in Google Scholar

[4]. W.T. Cefalu, F.B. Hu, Role of chromium in human health and in diabetes, Diabetic Care 27 (2004) 2741-2751.10.2337/diacare.27.11.2741Search in Google Scholar

[5]. A. D. Vaibhav, V. B. Prasad, SAR and computer aided drug design approaches in the discovery of peroxisome proliferator activated receptor activators: a perspective, Journal of Computational Medicine (2013) Article ID 406049.10.1155/2013/406049Search in Google Scholar

[6]. R.B. Tripathi, J. Jain, A.W. Siddiqui, Design of new peroxisome proliferators gamma activated receptor agonists (PPAR) via QSAR based modeling, Journal of Applied Pharmaceutical Science and Research 1 (2018) 23-26.10.31069/japsr.v1i01.13059Search in Google Scholar

[7]. S. Q. Pantaleao, D.G.V. Fujii, V.G. Maltarollo, D.C. Silva, G.H.G. Trossini, K.C. Weber, L.P.B. Scott, K.M. Honorio, The role of QSAR and virtual screening studies in Type 2 diabetes drug discovery, Medicinal Chemistry 13 (2017) 706-720.10.2174/1573406413666170522152102Search in Google Scholar

[8]. A.M. Chawla, P.Y. Chawla, R.K. Dhawan, QSAR study of 2,4-dioxothiazolidine antidiabetic compounds, Der Pharmacia Chemica 6 (2014) 103-110.Search in Google Scholar

[9]. S. Kesar, P. Mishra, P. Ojha, S. Singh, 2D QSAR study of potent GSK3β inhibitor for treatment of type II diabetes, International Journal of Pharmaceutical Science and Research 7 (2016) 2932-2943.Search in Google Scholar

[10]. J.V. Zivkovic, N.V. Trutic, J.B. Veselinovic, G.M. Nikolic, A.M. Veselinovic, Monte Carlo method based QSAR modelling of maleimide derivatives as glycogensynthasekinase-3β inhibitors, Computers in Biology and Medicine 64 (2015) 276-282.10.1016/j.compbiomed.2015.07.004Search in Google Scholar

[11]. V.K. Vyas, H.G. Bhatt, P.K. Patel, J. Jalu, C. Chintha, N. Gupta, M. Ghate, CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents, SAR and QSAR in Environmental Research 24 (2013) 519-551.10.1080/1062936X.2012.751553Search in Google Scholar

[12]. M. Lorca, C. Morales-Verdejo, D. Vásquez-Velásquez, J. Andrades-Lagos, J. Campanini-Salinas, J. Soto-Delgado, G. Recabarren-Gajardo, J. Mella, Structure activity relationships based on 3D-QSAR CoMFA/CoMSIA and design of aryloxypropanol-amine agonists with selectivity for the human β3-adrenergic receptor and anti-obesity and antidiabetic profiles, Molecules 23 (2018) 1191.10.3390/molecules23051191Search in Google Scholar

[13]. K.M. Manoj, K. Rajnish, M. Priyanka, In silico accounting of novel pyridazine analogues as h-PTP 1B inhibitors: pharmacophore modelling, atom-based 3D QSAR and docking studies, Medicinal Chemistry Research 23 (2014) 2701-2711.10.1007/s00044-013-0797-8Search in Google Scholar

[14]. L.L. Chang, K.L. Sidler, M.A. Cascieri, S.D. Laszlo, G. Koch, B. Li, M. MacCoss, N. Mantlo, S. O’Keefe, M. Pang, A. Rolando, W.K. Hagmann, Substituted imidazoles as glucagon receptor antagonists, Bioorganic and Medicinal Chemistry Letters 11 (2001) 2549-2553.10.1016/S0960-894X(01)00498-XSearch in Google Scholar

[15]. J. Borras, A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Minicione, C.T. Supuran, Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?, Bioorganic and Medicinal Chemistry 7 (1999) 2397-2406.Search in Google Scholar

[16]. D. Vullo, M. Franchi, E. Gallori, J. Antel, A. Scozzafava, C.T. Supuran, Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides, Journal of Medicinal Chemistry 47 (2004) 1272-1279.10.1021/jm031057+14971907Search in Google Scholar

[17]. J.Y. Winum, J.M. Dogne, A. Casini, X. De Leval, J.L. Montero, A. Scozzafava, D. Vullo, A. Innocenti, C.T. Supuran, Carbonic anhydrase inhibitors: Synthesis and inhibition of cytosolic membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties, Journal of Medicinal Chemistry 48 (2005) 2121-2125.10.1021/jm0494826Search in Google Scholar

[18]. V. Ravichandran, K. Venkateskumar, S. Shalini, R. Harish, Exploring the structure activity relationship of oxazolidinones as HIV-1 protease inhibitors-QSAR and pharmacophore modelling studies, Chemometerics and Intelligent Laboratory Systems 154 (2016) 52-61.10.1016/j.chemolab.2016.03.017Search in Google Scholar

[19]. V. Ravichandran, O.C. Chean, D. K. Subramaniam, N.M. Ying, S. Sivadasan, H. Rajak, A. Rasheed, Designing hypothesis of diaryl pyrimidine analogs as anti-HIV agent: QSAR approach, Medicinal Chemistry Research 22 (2013) 35-44.10.1007/s00044-012-0008-zSearch in Google Scholar

[20]. A. Guyon, A. Elisseeff, An introduction to variable and feature selection, Journal of Machine Learning Research 3 (2003) 1157-1182.Search in Google Scholar

[21]. R.B. Darlington, Regression and linear models, McGraw-Hill Higher Edu., New York, 23 (1990) 365-377.Search in Google Scholar

[22]. K. Hasegawa, T. Kimura, K. Funatsu, GA strategy for variable selection in QSAR studies: enhancement of comparative molecular binding energy analysis by GA based PLS method, Quantitative Structure Activity Relationship 18 (1999) 262-272.10.1002/(SICI)1521-3838(199907)18:3<262::AID-QSAR262>3.0.CO;2-SSearch in Google Scholar

[23]. W. Zheng, A. Tropsha, Novel variable selection quantitative structure-property relationship approach based on the k-Nearest-Neighbor principle, Journal of Chemical Informatics and Computer Science 40 (2000) 185-194.10.1021/ci980033m10661566Search in Google Scholar

[24]. V. Ravichandran, H. Rajak, A.K. Jain, S. Shalini, P.V. Christapher, R.K. Agrawal, Validation of QSAR models - Strategies and importance, International Journal of Drug Design and Discovery 2 (2011) 511-519Search in Google Scholar